Ricerca
Didattica
Soluzioni
Accedi
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Cancer Immunology Program
Vivien R. Sutton has not added Biography.
If you are Vivien R. Sutton and would like to personalize this page please email our Author Liaison for assistance.
A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death.
The Journal of cell biology Jan, 2003 | Pubmed ID: 12538642
Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors.
Immunity Mar, 2003 | Pubmed ID: 12648450
Purification of natural killer cell cytotoxic granules for assaying target cell apoptosis.
Journal of immunological methods May, 2003 | Pubmed ID: 12738359
Granzyme B: pro-apoptotic, antiviral and antitumor functions.
Current opinion in immunology Oct, 2003 | Pubmed ID: 14499262
A central role for Bid in granzyme B-induced apoptosis.
The Journal of biological chemistry Feb, 2005 | Pubmed ID: 15574417
A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death.
Transplantation Jan, 2006 | Pubmed ID: 16436955
Cytotoxic T lymphocyte-induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis.
The Journal of cell biology Apr, 2006 | Pubmed ID: 16606695
Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid.
Diabetes Aug, 2006 | Pubmed ID: 16873683
Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis.
The Journal of cell biology Feb, 2007 | Pubmed ID: 17283185
Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function.
Blood Aug, 2007 | Pubmed ID: 17475905
Measuring cell death mediated by cytotoxic lymphocytes or their granule effector molecules.
Methods (San Diego, Calif.) Mar, 2008 | Pubmed ID: 18314055
Dihydrofuro[3,4-c]pyridinones as inhibitors of the cytolytic effects of the pore-forming glycoprotein perforin.
Journal of medicinal chemistry Dec, 2008 | Pubmed ID: 19007200
Cathepsin H is an additional convertase of pro-granzyme B.
The Journal of biological chemistry Jul, 2010 | Pubmed ID: 20435891
Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L.
Immunology Oct, 2010 | Pubmed ID: 20497254
Proteases in lymphocyte killer function: redundancy, polymorphism and questions remaining.
Biological chemistry Aug, 2010 | Pubmed ID: 20731542
Cathepsin C limits acute viral infection independently of NK cell and CD8+ T-cell cytolytic function.
Immunology and cell biology May, 2011 | Pubmed ID: 20975734
A critical role for granzymes in antigen cross-presentation through regulating phagocytosis of killed tumor cells.
Journal of immunology (Baltimore, Md. : 1950) Aug, 2011 | Pubmed ID: 21709155
Activated mouse B cells lack expression of granzyme B.
Journal of immunology (Baltimore, Md. : 1950) Apr, 2012 | Pubmed ID: 22427643
A novel role for granzymes in anti-tumor immunity.
Oncoimmunology Mar, 2012 | Pubmed ID: 22720248
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.
Blood Apr, 2013 | Pubmed ID: 23377437
Granzyme h is a novel protease expressed by human mast cells.
International archives of allergy and immunology , 2014 | Pubmed ID: 25342632
Peter MacCallum Cancer Centre
Magdalena Hagn1,
Vivien R. Sutton1,
Joseph A. Trapani1
1Cancer Immunology Program, Peter MacCallum Cancer Centre
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
Copyright © 2024 MyJoVE Corporation. Tutti i diritti riservati